EMS While on Accutane / Isotretinoin: What to Know
About the Authors
Bertica M. Rubio, M.D.
Medical Director, Antiaging Regenerative Medicine Clinic | Board-Certified Physician | Dartmouth Medical School
Dr. Bertica M. Rubio is a board-certified physician and Medical Director of the Antiaging Regenerative Medicine Clinic in Redlands, California. She earned her Bachelor of Science degree from Loyola Marymount University and her Doctor of Medicine from Dartmouth Medical School (Geisel School of Medicine). She completed her pediatrics residency at UC Irvine Medical Center.
With decades of clinical experience, Dr. Rubio specializes in age management medicine, regenerative medicine, wound healing, and growth factor therapies. Her practice integrates evidence-based medical science with advanced aesthetic and regenerative treatments, helping patients achieve optimal health and youthful vitality.
Dr. Rubio is passionate about educating patients on the science behind skincare, facial rejuvenation, and non-invasive technologies like EMS (Electrical Muscle Stimulation) for facial toning. Her articles for PureLift LAB combine rigorous medical knowledge with practical guidance for achieving real, lasting results.
Andrew Conrad Barile, PT, DPT
Doctorate of Physical Therapy (DPT), Licensed Physical Therapist (PT)
Dr. Andrew Conrad Barile is a Doctor of Physical Therapy and the CEO and Founder of Xtreem Pulse LLC. He earned his Doctorate in Physical Therapy from Daemen College and brings over two decades of clinical and entrepreneurial experience in pediatric physical therapy, craniosacral therapy, and medical device innovation. His deep understanding of human anatomy, muscle physiology, and therapeutic technology provides invaluable science-backed approach to facial rejuvenation and anti-aging solutions.
Daniel Grinberg, MD, FACS
Board-Certified Otolaryngologist & Head and Neck Surgeon | Fellow, American College of Surgeons | Assistant Clinical Professor, Mount Sinai School of Medicine
Daniel Grinberg, MD, FACS is a Board-Certified Otolaryngologist and Head & Neck Surgeon at ENT and Allergy Associates in West Nyack, NY. He earned his medical degree from Columbia University College of Physicians and Surgeons, completed his Otolaryngology residency at New York University Medical Center, and serves as Assistant Clinical Professor at Mount Sinai School of Medicine. He is a Fellow of both the American College of Surgeons and the American Academy of Otolaryngology.
Dr. Grinberg's head-and-neck surgical perspective brings PureLift LAB readers a wider clinical lens — connecting at-home EMS practice to the underlying medical anatomy with the same scientific rigor we apply to every device specification.
Prof. Dr. med. Ivo Buschmann
Chair of Angiology, Medizinische Hochschule Brandenburg | Clinic Director, University Clinic for Angiology, Brandenburg University Hospital | Former Senior Consultant, Charité Universitätsmedizin Berlin
Prof. Dr. med. Ivo Buschmann is Chair of Angiology at the Medizinische Hochschule Brandenburg Theodor Fontane (MHB) and Clinic Director of the University Clinic for Angiology at the Brandenburg University Hospital. He completed his medical training at the University of Hamburg, served as a Max-Planck Society Fellow at the Max-Planck-Institute for Heart and Lung Research, and held senior consultant positions at the Charité Universitätsmedizin Berlin Campus Virchow before being appointed Chair at MHB in 2016.
Prof. Buschmann is one of Europe's leading authorities on arteriogenesis — the flow-driven growth and remodeling of blood vessels — with more than 150 peer-reviewed publications and several US and EU patents on devices that stimulate collateral blood vessel growth through controlled shear-rate therapy. His research connects mechanical and electrical stimulation to vascular adaptation, microcirculation, and tissue perfusion.
Prof. Buschmann's contributions bring PureLift LAB readers a vascular-biology perspective that complements our existing clinical, physical-therapy, and surgical-anatomy authorship — explaining how EMS stimulation engages not only facial muscles but also the microcirculation that supplies them, and why smart delivery matters at the level of blood flow as much as muscle contraction.
Share
Isotretinoin — sold under brand names including Accutane, Roaccutane, Absorica, and Claravis — is one of the most powerful medications in dermatology. It treats severe, persistent acne by dramatically reducing oil gland activity. It is also one of the most skin-sensitizing medications on the market: while on it, your skin is significantly more reactive to topical actives, mechanical interventions, and any procedure that disrupts the skin barrier.
The question PureLift users on isotretinoin reasonably ask: can you continue EMS during treatment, or is the answer "pause and resume later"?
The short version
- Pause PureLift use during isotretinoin treatment. The standard skin-sensitivity profile during isotretinoin makes facial EMS less productive and more likely to cause irritation.
- Wait 6 months after completing your isotretinoin course before resuming EMS. This aligns with the standard dermatology guidance for resuming other device-based or invasive skincare interventions.
- Some dermatologists may clear resumption sooner depending on your specific course, dosage, and how your skin recovers. Defer to your dermatologist's specific protocol.
- EMS in entirely untreated areas may continue if your dermatologist clears it. But for most users, pausing entirely until the course completes is the simpler approach.
Why the pause is necessary
Isotretinoin works by shrinking sebaceous glands and reducing oil production. The effect on the rest of the skin is significant. During treatment, users typically experience:
- Significantly thinned stratum corneum and reduced barrier function
- Severe facial dryness, often with flaking and cracking around the lips and nose
- Increased photosensitivity
- Higher reactivity to mechanical pressure, friction, and topical actives
- Slower wound healing — meaning small injuries to the skin take longer to resolve than they would in untreated skin
Running EMS over isotretinoin-treated skin amplifies all of these effects. The conductive serum, the probe contact, and the muscle engagement combine to produce more visible irritation than usable session value. More importantly, the slower wound healing means any minor injury — surface friction, scratches, or contact-induced micro-tears — can become a more persistent issue.
This is the same reason dermatologists advise against waxing, threading, microdermabrasion, chemical peels, microneedling, and laser treatments during and immediately after isotretinoin courses.
The 6-month wait after completion
The standard dermatology guidance for resuming aggressive cosmetic procedures (laser, microneedling, peels) after isotretinoin is 6 months. This is the same window we recommend for EMS.
The reasoning: while isotretinoin's circulating levels drop quickly after treatment ends, the structural effects on skin — barrier function, oil production, wound healing — take months to normalize. Six months is the established window for full skin recovery and the resumption of normal cosmetic procedure tolerance.
Some dermatologists are now publishing data on shorter post-isotretinoin waits, particularly for lower-cumulative-dose courses. If you finished a low-dose isotretinoin protocol (e.g., 0.1–0.3 mg/kg/day for 6 months as a maintenance protocol), your dermatologist may clear EMS resumption at 3 months rather than 6. Defer to your dermatologist's specific assessment — there is real medical variation in the protocols.
If you're considering starting isotretinoin while using PureLift
Three things to plan for:
The pause will be 6–10 months total. A standard isotretinoin course is 4–6 months on the medication plus 6 months post-course wait. Plan your PureLift routine accordingly — many users finish a current PureLift cycle, pause for the isotretinoin window, and resume after the wait.
Your post-isotretinoin skin will be different. Many users find their skin tolerates EMS better post-isotretinoin than before treatment, because the underlying acne triggers that made sessions uncomfortable are now resolved. The resumption can be a positive recalibration.
Your dermatologist is the right person to coordinate this. A dermatologist managing your isotretinoin course can give you specific timing guidance and the all-clear for resuming EMS at the right point.
If you're already on isotretinoin and just bought PureLift
PureLift's 30-day return policy applies. If your situation has changed and you cannot use the device, return it for a full refund. Pick it up again after your post-isotretinoin window has cleared.
What to do during the pause
Several skincare interventions support skin during and after isotretinoin without conflicting with the medication:
- Bland, fragrance-free moisturizers — ceramide-based formulations are particularly helpful
- Petroleum jelly or Aquaphor on lips multiple times per day (lips are typically the first and worst-affected area)
- Gentle, non-foaming cleansers — avoid acid-based washes
- Sunscreen, daily, broad-spectrum SPF 30+ (isotretinoin substantially increases photosensitivity)
- Hydrating mists and humectants
Avoid retinoids (already getting one through systemic isotretinoin), acid exfoliants, manual exfoliation, scrubs, and aggressive masks during treatment.
The bottom line
Isotretinoin and facial EMS do not combine well. The dermatology-standard guidance is to pause cosmetic device-based interventions during the course and for 6 months after completion. PureLift fits this pattern. Plan the routine pause around your treatment, support your skin with bland barrier-care during the window, and resume EMS once your dermatologist clears it.
For other sensitivity-related framing, see EMS for Rosacea, Eczema, and Reactive Skin. For routine pauses generally, see our pregnancy guide.
This article is general guidance, not medical advice. Defer to your dermatologist on isotretinoin-specific timing.